ZimVie, Inc. (NASDAQ: ZIMV) is a global dental solutions company focused on the research, development, manufacturing and commercialization of dental implants, restorative components, digital dentistry platforms and surgical instruments. Formed in April 2022 as a spin-off from Zimmer Biomet, ZimVie combines a heritage of orthopedic and dental innovation with a dedicated focus on meeting the evolving needs of dental professionals. The company’s offerings span implant systems, biologics, prosthetics and regenerative materials designed to support a comprehensive patient care continuum—from diagnostics and treatment planning to post-operative care.
ZimVie’s product portfolio includes endosseous dental implants in a variety of designs and surface technologies, abutments and prosthetic components, guided surgery tools, bone grafting materials and soft tissue management solutions. The company has also invested in digital workflow platforms that enable clinicians to plan implant placement virtually, fabricate custom prosthetics and monitor patient outcomes. By integrating hardware, software and biologic solutions, ZimVie aims to simplify clinical workflows, enhance procedural predictability and improve patient experiences.
Headquartered in Palm Beach Gardens, Florida, ZimVie operates a network of manufacturing, research and distribution facilities across North America, Europe, Asia Pacific and Latin America. Its global footprint supports direct and partner-based sales channels, delivering products and services to dental practitioners, laboratories and healthcare institutions. Since its launch, the company has leveraged its legacy in medical device manufacturing to expand into emerging markets and pursue strategic partnerships that accelerate product innovation and market penetration.
Under the leadership of President and Chief Executive Officer Bryan Hanson, ZimVie is guided by a management team with extensive experience in dentistry, medical technology and life sciences. The company maintains a strong commitment to research and development, investing in clinical studies, digital innovation and regenerative science. As ZimVie continues to build on its heritage, it remains focused on delivering solutions that address both current clinical needs and the future of restorative and regenerative dentistry.
AI Generated. May Contain Errors.